Skip to main content

Table 1 Delphi survey participant characteristics

From: Developing principles for sharing information about potential trial intervention benefits and harms with patients: report of a modified Delphi survey

Stakeholder group

Participants in round 1 (n = 250)

Participants in round 2 (n = 201)

Public and patient representatives

57

46

Research ethics committee members and other approvals staff

36

33

Industry (including medico-legal experts)

24

15

Applied researchers, including psychologists and risk communicators

26

18

Research nurses, clinical trial managers and trialists

84

74

Others (including quality assurance managers, quality assurance auditors, clinical auditors, pharmacists, PhD students, sponsor representatives, research midwives and principal scientists)

23

15